Correlation Between 908 Devices and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both 908 Devices and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 908 Devices and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 908 Devices and Relay Therapeutics, you can compare the effects of market volatilities on 908 Devices and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 908 Devices with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 908 Devices and Relay Therapeutics.
Diversification Opportunities for 908 Devices and Relay Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 908 and Relay is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding 908 Devices and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and 908 Devices is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 908 Devices are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of 908 Devices i.e., 908 Devices and Relay Therapeutics go up and down completely randomly.
Pair Corralation between 908 Devices and Relay Therapeutics
Given the investment horizon of 90 days 908 Devices is expected to under-perform the Relay Therapeutics. In addition to that, 908 Devices is 1.02 times more volatile than Relay Therapeutics. It trades about -0.03 of its total potential returns per unit of risk. Relay Therapeutics is currently generating about -0.02 per unit of volatility. If you would invest 1,082 in Relay Therapeutics on August 30, 2024 and sell it today you would lose (602.00) from holding Relay Therapeutics or give up 55.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
908 Devices vs. Relay Therapeutics
Performance |
| Timeline |
| 908 Devices |
| Relay Therapeutics |
908 Devices and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 908 Devices and Relay Therapeutics
The main advantage of trading using opposite 908 Devices and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 908 Devices position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| 908 Devices vs. Inari Medical | 908 Devices vs. CONMED | 908 Devices vs. Glaukos Corp | 908 Devices vs. Nevro Corp |
| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |